Categories: News

EssilorLuxottica: First-Quarter 2023 Revenue Conference Call Invitation

FirstQuarter 2023 Revenue
Conference Call Invitation

Mr STEFANO GRASSI, Chief Financial Officer, and
Mr GIORGIO IANNELLA, Head of Investor Relations,
have the pleasure of inviting you to our First-Quarter 2023 Revenue Conference Call on:

Thursday, April 20, 2023, at 6:30 pm CEST

Please note that both the Press Release publication and the Conference Call start have been moved to the evening time, i.e. 6:00 pm CEST for the Press Release and 6:30 pm CEST for the Conference Call.

Dial-in telephone access

If you wish to dial into the conference call, please pre-register at the following link to receive personal credentials (Dial-in numbers, Conference ID and User ID):

https://aiti.capitalaudiohub.com/essilorluxottica/reg.html

If you encounter any issue in the pre-registration phase you may contact ir@essilorluxottica.com, providing your name and surname and the name of your company.

Live webcast

You can watch the presentation at the following link:

https://streamstudio.world-television.com/1217-2090-35663/en

The press release will be published at 6:00 pm CEST on the same day and the presentation slides will be made available prior to the call. Both can be found on https://www.essilorluxottica.com/investors.

Attachment

Staff

Recent Posts

BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 12, 2024) - BioHarvest Sciences Inc. (CSE:…

42 mins ago

Akanda Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

London, United Kingdom--(Newsfile Corp. - June 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…

3 hours ago

Canadian Insulin Leading the Way With Affordable Wegovy North of the Border

Americans Save Big on Wegovy with Canadian Insulin’s Prescription Referral Service REGINA, SK / ACCESSWIRE…

3 hours ago

Women in Science? At Merck, Absolutely

NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Merck & Co., Inc.Strong career paths…

3 hours ago

Pearl Enables Advanced AI Imaging for New Ora All-in-One Dental Software Platform

The new partnership brings Pearl’s industry-leading dental AI capabilities to groundbreaking new all-in-one practice management…

6 hours ago

Simpson Interventions Announces Appointment of Dr. Joseph Knight as CEO

Prior CEO and Founder, Dr. John Simpson, to Remain with Company as Chief Medical Officer…

6 hours ago